Tatva Chintan Pharma Chem Limited — Quarterly Results & Earnings

₹1052.40

-5.07%

Profit Growth YoY1603.03%Latest quarter

Sales Growth YoY47.95%Latest quarter

Sales CAGR 5Y7.77%5 year compound

Profit CAGR 5Y-31.41%5 year compound

📋

Quarterly Performance

YoY Profit Growth+1603.03%

🔥 Exceptional growth

YoY Sales Growth+47.95%

🔥 Exceptional growth

OPM 5Y Average

Operating profit margin

17.54%

EPS Growth 5Y

-44.61%

Interest Coverage

Higher = safer debt servicing

15.20

ROE

0.78%

ROCE

1.20%

💡

Growth Analysis

Tatva Chintan Pharma Chem Limited reported YoY profit growth of 1603.03% and revenue growth of 47.95% in the latest quarter. Double-digit profit growth above 20% is exceptional — indicates strong business momentum. Over 5 years, sales compounded at 7.77% and profits at -31.41% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Tatva Chintan Pharma Chem Limited

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Specialty Chemicals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.